NK Cell Functional Impairment after Allogeneic Hematopoietic Stem Cell Transplantation Is Associated with Reduced Levels of T-bet and Eomesodermin

NK cells play a major role in protection against tumor recurrence and infection after allogeneic hematopoietic stem cell transplantation (HSCT). It has been shown that NK cell function after HSCT is impaired, but underlying molecular mechanisms are not well-known. In this report we show that the level of T-bet and Eomesodermin (Eomes), two T-box transcription factors regulating lymphocyte effector functions, is strongly reduced in NK cells from HSCT recipients compared with healthy control subjects. Reduction of T-bet and Eomes expression appeared early and persisted for years after HSCT, affecting all peripheral blood NK cells independently of their differentiation status. Reduced T-bet levels in NK cells from allogeneic HSCT recipients significantly correlated with reduced perforin expression. Acute, but not chronic, graft-versus-host disease, as well as CMV reactivation, was associated with further downregulation of T-bet expression in NK cells. Lower levels of T-bet expression in NK cells were associated with less favorable outcome after HSCT as a result of increased nonrelapse mortality. Collectively, our results provide a possible molecular explanation for the previously reported functional exhaustion of NK cells after allogeneic HSCT and suggest an impact of the NK transcriptional machinery status on HSCT outcome.

[1]  C. Chougnet,et al.  The aged nonhematopoietic environment impairs natural killer cell maturation and function , 2015, Aging cell.

[2]  Nicolás I Torres,et al.  IL‐27 stimulates human NK‐cell effector functions and primes NK cells for IL‐18 responsiveness , 2015, European journal of immunology.

[3]  O. Mandelboim,et al.  NK cell development in bone marrow and liver: site matters , 2014, Genes and Immunity.

[4]  O. Lambotte,et al.  High Eomesodermin Expression among CD57+ CD8+ T Cells Identifies a CD8+ T Cell Subset Associated with Viral Control during Chronic Human Immunodeficiency Virus Infection , 2014, Journal of Virology.

[5]  Hyun-Dong Chang,et al.  NK cells gain higher IFN‐γ competence during terminal differentiation , 2014, European journal of immunology.

[6]  O. Mandelboim,et al.  NK Cell Receptor NKp46 Regulates Graft-versus-Host Disease , 2014, Cell reports.

[7]  M. Betts,et al.  Characterization of T-Bet and Eomes in Peripheral Human Immune Cells , 2014, Front. Immunol..

[8]  Satoru Takahashi,et al.  T-bet and Eomes instruct the development of two distinct natural killer cell lineages in the liver and in the bone marrow , 2014, The Journal of experimental medicine.

[9]  A. Agha,et al.  KLRG1+ NK Cells Protect T-bet–Deficient Mice from Pulmonary Metastatic Colorectal Carcinoma , 2014, The Journal of Immunology.

[10]  E. Riley,et al.  Functional Significance of CD57 Expression on Human NK Cells and Relevance to Disease , 2013, Front. Immunol..

[11]  H. Kohrt,et al.  Rapid development of exhaustion and down-regulation of eomesodermin limit the antitumor activity of adoptively transferred murine natural killer cells. , 2012, Blood.

[12]  T. Niki,et al.  Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9. , 2012, Blood.

[13]  Sharline Madera,et al.  The transcription factors T-bet and Eomes control key checkpoints of natural killer cell maturation. , 2012, Immunity.

[14]  Jeffrey S. Miller,et al.  NK cell education after allogeneic transplantation: dissociation between recovery of cytokine-producing and cytotoxic functions. , 2011, Blood.

[15]  P. J. Norris,et al.  Expansion of a unique CD57+NKG2Chi natural killer cell subset during acute human cytomegalovirus infection , 2011, Proceedings of the National Academy of Sciences.

[16]  P. Debré,et al.  CD56brightCD16+ NK Cells: A Functional Intermediate Stage of NK Cell Differentiation , 2011, The Journal of Immunology.

[17]  H. Pircher,et al.  CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset. , 2010, Blood.

[18]  J. Passweg,et al.  CD56bright NK cells after hematopoietic stem cell transplantation are activated mature NK cells that expand in patients with low numbers of T cells , 2010, European journal of immunology.

[19]  R. Negrin,et al.  NK cells mediate reduction of GVHD by inhibiting activated, alloreactive T cells while retaining GVT effects. , 2010, Blood.

[20]  M. Bevan,et al.  Interleukin-2 and inflammation induce distinct transcriptional programs that promote the differentiation of effector cytolytic T cells. , 2010, Immunity.

[21]  A. Rao,et al.  Runx3 and T-box proteins cooperate to establish the transcriptional program of effector CTLs , 2009, The Journal of experimental medicine.

[22]  J. Passweg,et al.  Reconstitution of the immune system after hematopoietic stem cell transplantation in humans , 2008, Seminars in Immunopathology.

[23]  M. Robin,et al.  An Unusual CD56brightCD16low NK Cell Subset Dominates the Early Posttransplant Period following HLA-Matched Hematopoietic Stem Cell Transplantation1 , 2008, The Journal of Immunology.

[24]  M. Robin,et al.  An unusual CD56(bright) CD16(low) NK cell subset dominates the early posttransplant period following HLA-matched hematopoietic stem cell transplantation. , 2008, Journal of immunology.

[25]  M. Caligiuri,et al.  Transcriptional control of human T‐BET expression: The role of Sp1 , 2007, European journal of immunology.

[26]  B. Chapuis,et al.  Can only partial T-cell depletion of the graft before hematopoietic stem cell transplantation mitigate graft-versus-host disease while preserving a graft-versus-leukemia reaction? A prospective phase II study. , 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[27]  E. Wherry,et al.  Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin , 2005, Nature Immunology.

[28]  P. Farnham,et al.  T-bet regulates the terminal maturation and homeostasis of NK and Valpha14i NKT cells. , 2004, Immunity.

[29]  Hao Shen,et al.  Control of Effector CD8+ T Cell Function by the Transcription Factor Eomesodermin , 2003, Science.

[30]  D. Foster,et al.  IL-21 in Synergy with IL-15 or IL-18 Enhances IFN-γ Production in Human NK and T Cells1 , 2003, The Journal of Immunology.

[31]  D. Foster,et al.  IL-21 in synergy with IL-15 or IL-18 enhances IFN-gamma production in human NK and T cells. , 2003, Journal of immunology.